Skip to Content
Søk Menu
11-14 oktober 2023

Håll utkik när vi täcker EADV 2023 I European Academy of Dermatology and Venereology

News from EADV 2023

Bianca Maria Piraccini

Severe alopecia areata: JAK-inhibitor increase hair regrowth and improve quality of life

/ Bianca Maria Piraccini
Alopecia areataEADV23 Play the Video

Marjolein de Bruin-Weller

Personalized Medicine on the Horizon for Atopic Dermatitis

/ Marjolein de Bruin-Weller
EADV23 Play the Video
Ida Vittrup

Risk Factors for JAK-Inhibitor Treatment in Atopic Dermatitis

/ Ida Vittrup
Atopisk dermatitEADV23 Play the Video
Stephan Weidinger

New Treatments for Atopic Dermatitis to Come

/ Stephan Weidinger
Atopisk dermatitEADV23 Play the Video
Lisa Schots

Concentration of Ixekizumab Paving the Way Towards Personalized Therapy in Psoriasis

/ Lisa Schots
PsoriasisEADV23 Play the Video
Stephan Weidinger

New Insights into Type 2 Inflammation in Atopic Dermatitis

/ Stephan Weidinger
Atopisk dermatitEADV23 Play the Video
Kim Papp

Deucravacitinib: Significantly Improved Symptoms and Signs of Psoriasis in Patients with Psoriasis

/ Kim Papp
PsoriasisEADV23 Play the Video
Enikö Sonkoly

New Oral Drug Sotyktu for Plaque Psoriasis Patients Demonstrates Promising Results with Favorable Safety Profile

/ Enikö Sonkoly
PsoriasisEADV23 Play the Video
Stephan Weidinger

AD: New knowledge about Type 2 inflammation and skin barrier deficiency

/ Stephan Weidinger
Atopisk dermatitEADV23Inflammation Play the Video
Enikö Sonkoly

An overview of the exciting news from EADV 2023

/ Enikö Sonkoly
EADV23 Play the Video
Andreas Pinter

New and promising treatments for psoriasis

/ Andreas Pinter
PsoriasisEADV23 Play the Video

EADV 2022

April Armstrong

Therapies for atopic dermatitis for special populations of patients

/ April Armstrong
Atopisk dermatitEADV22 Play the Video

Treatment of severe atopic dermatitis in a pediatric population

/ Ida Vittrup
Atopisk dermatitEADV22 Play the Video

Severe atopic dermatitis in a pediatric population – Epidemiology, pathophysiology, and comorbidities

/ Ida Vittrup
Atopisk dermatitEADV22 Play the Video
Thrasyvoulos Tzellos

Bacterial resistance in Hidradenitis suppurativa: an update

/ Thrasyvoulos Tzellos
Hidradenitis SuppurativaEADV22 Play the Video
Trinidad Montero Vilchez

When are hormonal agents indicated in acne?

/ Trinidad Montero-Vilchez
EADV22 Play the Video
Laura von Kobyletzki

A Nationwide E-health Platform for Atopic Dermatitis

/ Laura von Kobyletzki
Atopisk dermatitEADV22 Play the Video
Ida Vittrup

New study sheds light on the link between atopic dermatitis and academic achievement in childhood and youth

/ Ida Vittrup
Atopisk dermatitEADV22Ungdomar Play the Video
Hans Peter Soyer

The Relevance of AI in Dermatology

/ Hans Peter Soyer
MelanomEADV22 Play the Video
Deirdre Murrell

Gender Equity in Dermatology

/ Deirdre Murrell
EADV22 Play the Video
Pedro Mendes-Bastos

Treatment of Severe Atopic Dermatitis (AD)

/ Pedro Mendes Bastos
Atopisk dermatitEADV22 Play the Video
Deirdre Murrell

The role of JAK and BTK inhibitors in dermatology

/ Deirdre Murrell
JAK-hämmareEADV22 Play the Video
Charlotte Näslund Koch

Does smoking really cause psoriasis?

/ Charlotte Näslund Koch
PsoriasisEADV22 Play the Video
Load more

EADV 2021

Annarita Antelmi

How to recognize and manage hair dye allergy

/ Annarita Antelmi
AllergiEADV21 Play the Video
Eniko Sonkoly

Existing and upcoming small molecules in psoriasis treatment

/ Enikö Sonkoly
PsoriasisEADV21 Play the Video
Filippa Nyberg

Sjögren’s syndrome is a common disease, but unfortunately neglected

/ Filippa Nyberg
EADV21 Play the Video
Álvaro González-Cantero

Vaccine hesitancy driven by safety concerns

/ Álvaro González-Cantero
PsoriasisCOVID-19EADV21 Play the Video

The risk of infections in psoriasis patients treated with biologics during the COVID-19 pandemic

/ Lara van der Schoot / Juul van den Reek
PsoriasisCOVID-19EADV21 Play the Video
Dimitrios Ioannides

Psoriasis has significant negative impact on quality of life

/ Dimitrios Loannides
PsoriasisEADV21 Play the Video
Load more
Andrew Blauvelt

Switching from biology treatment of AD to a JAK inhibitor resulted in improved efficacy

/ Andrew Blauvelt
Atopisk dermatitEADV21 Play the Video

Missa inte de senaste nyheterna från Dermatologi

Registrera dig och få nya artiklar, MEDtalks, MEDcast, professionella tester och tidskrifter i din inkorg

Få tillgang

Mere från EADV 2020

EADV20: Complete treatment of psoriatic disease

/ Kristian Reich
PsoriasisEADV20 Play the Video

EADV20: Baricitinib – the first JAK-inhibitor for treatment of patients with atopic dermatitis

/ Kristian Reich
JAK-hämmareEADV20Atopisk dermatit Play the Video

EADV20: Oral and topical treatment of Psoriasis now and in the future

/ Enikö Sonkoly
PsoriasisEADV20 Play the Video

EADV20: Sonelokinab – an IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F in patients with moderate to severe chronic plaque-type psoriasis

/ Kim Papp
PsoriasisEADV20 Play the Video

Abstract: Orala selektiva JAK-hämmare ­nya behandlingsmöjligheter av atopisk dermatit på väg

JAK-hämmareEADV20Atopisk dermatit

EADV20: Optimizing outcomes in moderate-to-severe atopic dermatitis

/ Lawrence Eichenfield
EADV20Atopisk dermatit Play the Video
Back to top